Aktis Oncology Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 4.84 M | $155.86 M | 0.00% | 8.75% |
| ECOR1 CAPITAL, LLC | 08/14/2026 | 4.82 M | $155.49 M | 0.00% | 8.73% |
| BLUE OWL CAPITAL HOLDINGS LP | 08/11/2026 | 3.07 M | $98.95 M | -2.88% | 5.55% |
| BLACKROCK, INC. | 08/07/2026 | 2.28 M | $73.43 M | 7.87% | 4.12% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 2.05 M | $66.12 M | -3.41% | 3.71% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 1.97 M | $63.37 M | -15.14% | 3.56% |
| RTW INVESTMENTS, LP | 08/14/2026 | 1.59 M | $51.31 M | 0.00% | 2.88% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 1.31 M | $42.36 M | -12.55% | 2.38% |
| JUPITER TOPCO LLC | 08/14/2026 | 1.31 M | $42.36 M | 100.00% | 2.38% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 996.35 K | $32.11 M | 0.00% | 1.80% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2026 | 960.85 K | $30.97 M | 0.00% | 1.74% |
| MERCK & CO., INC. | 08/07/2026 | 952.84 K | $30.71 M | 0.00% | 1.72% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 817.08 K | $26.33 M | -2.02% | 1.48% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 763.50 K | $24.61 M | -51.19% | 1.38% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2026 | 696.56 K | $22.45 M | 100.00% | 1.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 520.74 K | $16.79 M | 5.85% | 0.94% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/14/2026 | 507.00 K | $16.34 M | 0.00% | 0.92% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2026 | 484.20 K | $15.61 M | 3.34% | 0.88% |
| STATE STREET CORP | 08/07/2026 | 484.01 K | $15.60 M | 13.02% | 0.88% |
| AH CAPITAL MANAGEMENT, L.L.C. | 08/14/2026 | 415.00 K | $13.38 M | 0.00% | 0.75% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2026 | 290.00 K | $9.35 M | 0.00% | 0.52% |
| FMR LLC | 08/13/2026 | 285.63 K | $9.21 M | -26.07% | 0.52% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/13/2026 | 245.87 K | $7.92 M | -25.37% | 0.44% |
| NORTHERN TRUST CORP | 08/13/2026 | 180.58 K | $5.82 M | 20.81% | 0.33% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 166.84 K | $5.38 M | 2.98% | 0.30% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 166.84 K | $5.38 M | 100.00% | 0.30% |
| BARCLAYS PLC | 08/14/2026 | 151.70 K | $4.89 M | 1,460.02% | 0.27% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 145.22 K | $4.68 M | 20.69% | 0.26% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 133.83 K | $4.31 M | 5.05% | 0.24% |
| TD ASSET MANAGEMENT INC | 08/04/2026 | 105.90 K | $3.41 M | 4.89% | 0.19% |
| SOROS FUND MANAGEMENT LLC | 08/14/2026 | 100.00 K | $3.22 M | 0.00% | 0.18% |
| WOODLINE PARTNERS LP | 08/14/2026 | 100.00 K | $3.22 M | 0.00% | 0.18% |
| UBS GROUP AG | 08/13/2026 | 99.96 K | $3.22 M | -71.70% | 0.18% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 95.40 K | $3.07 M | 100.00% | 0.17% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 72.84 K | $2.35 M | 4.16% | 0.13% |
| POLEN CAPITAL MANAGEMENT LLC | 08/04/2026 | 63.51 K | $2.05 M | 100.00% | 0.11% |
| MORGAN STANLEY | 08/13/2026 | 62.64 K | $2.02 M | 103.87% | 0.11% |
| TOROSO INVESTMENTS, LLC | 08/13/2026 | 57.06 K | $1.84 M | 100.00% | 0.10% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 50.46 K | $1.63 M | 100.00% | 0.09% |
| NUVEEN, LLC | 08/11/2026 | 49.82 K | $1.61 M | 103.60% | 0.09% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 49.25 K | $1.59 M | 14.80% | 0.09% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 48.12 K | $1.55 M | 100.00% | 0.09% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 08/14/2026 | 48.04 K | $1.55 M | 2.24% | 0.09% |
| QUANTINNO CAPITAL MANAGEMENT LP | 08/13/2026 | 46.89 K | $1.51 M | 100.00% | 0.08% |
| GREAT LAKES ADVISORS, LLC | 08/10/2026 | 43.61 K | $1.41 M | 100.00% | 0.08% |
| MIRADOR CAPITAL PARTNERS LP | 07/07/2026 | 40.12 K | $1.29 M | 100.00% | 0.07% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 38.38 K | $1.24 M | 100.00% | 0.07% |
| JUMP FINANCIAL, LLC | 08/13/2026 | 32.78 K | $1.06 M | 100.00% | 0.06% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2026 | 32.44 K | $1.05 M | 100.00% | 0.06% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 30.91 K | $996.36 K | 100.00% | 0.06% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aktis Oncology Inc institutional Ownership - FAQ's
During the previous two years, 153 institutional investors and hedge funds held shares of Aktis Oncology Inc. The most heavily invested institutionals were:
BioImpact Capital LLC: 4.84 M
EcoR1 Capital, LLC: 4.82 M
Blue Owl Capital Holdings LP: 3.07 M
BlackRock, Inc.: 2.28 M
T. Rowe Price Investment Management, Inc.: 2.05 M
WELLINGTON MANAGEMENT GROUP LLP: 1.97 M
62.12% of Aktis Oncology Inc stock is owned by institutional investors.
Institutional investors have bought a total of 37.91 M shares in the last 24 months. This purchase volume represents approximately $722.50 M in transactions.